F-Diseases’ Surveillance Data

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
L01FG01	AVASTIN	BioTech	Bevacizumab - 400mg	400mg	Injectable concentrated solution	75,875,312 L.L
L04AC16	TREMFYA	BioTech	Guselkumab - 100mg/ml	100mg/ml	Injectable solution	190,195,151 L.L
M03AX01	NEURONOX	BioTech	Clostridium botulinum type A neurotoxin complex - 100units	100units	Injectable lyophilised powder for solution	13,011,437 L.L
B01AB05	ENOMEX	BioTech	Enoxaparin sodium - 8000U Anti-Xa/0.8ml	8000U Anti-Xa/0.8ml	Injectable solution	1,025,160 L.L
L01FG01	BEVACIREL	BioTech	Bevacizumab - 400mg/16ml	400mg/16ml	Injectable solution	49,744,595 L.L
L04AC16	TREMFYA	BioTech	Guselkumab - 100mg/ml	100mg/ml	Injectable solution	190,195,151 L.L
M03AX01	XEOMIN	BioTech	Clostridium botulinum type A neurotoxin complex - 100 units LD50	100 units LD50	Injectable powder for solution	20,517,541 L.L
B01AB05	ENOXA MEDIS	BioTech	Enoxaparin sodium - 8,000U Anti-Xa/0.8ml	8,000U Anti-Xa/0.8ml	Injectable solution	963,535 L.L
L01FG01	BIVASTINA 400	BioTech	Bevacizumab - 400mg/16ml	400mg/16ml	Injectable concentrate for solution	92,353,609 L.L
L04AC18	SKYRIZI	BioTech	Risankizumab - 75mg	75mg	Injectable solution	194,911,251 L.L
M03AX01	DYSPORT	BioTech	Clostridium botulinum type A neurotoxin complex - 300units	300units	Injectable powder for solution	14,625,182 L.L
B01AB05	ENOXAMED	BioTech	Enoxaparin sodium - 8000IU Anti-XA/0.8ml	8000IU Anti-XA/0.8ml	Injectable solution	963,535 L.L
L01FG01	BIVASTINA 400	BioTech	Bevacizumab - 400mg/16ml	400mg/16ml	Injectable concentrate for solution	53,111,763 L.L
L04AC18	SKYRIZI	BioTech	Risankizumab - 150mg	150mg	Injectable solution	194,911,251 L.L
M03AX01	DYSPORT	BioTech	Clostridium botulinum type A neurotoxin complex - 500units	500units	Injectable powder for solution	42,726,155 L.L
B01AB05	ENOXAMED	BioTech	Enoxaparin sodium - 8000IU Anti-XA/0.8ml	8000IU Anti-XA/0.8ml	Injectable solution	4,575,784 L.L
L01FG01	MVASI	BioTech	Bevacizumab - 400mg/16ml	400mg/16ml	Injectable concentrate for solution	58,035,926 L.L
L04AC19	ENSPRYNG	BioTech	Satralizumab - 120mg/ml	120mg/ml	Injectable solution	857,061,795 L.L
M03AX01	NEURONOX	BioTech	Clostridium botulinum type A neurotoxin complex - 200units	200units	Injectable lyophilised powder for solution	25,175,058 L.L
B01AB05	LOVENOX	BioTech	Enoxaparin sodium - 8000UI (80mg)/0.8ml	8000UI (80mg)/0.8ml	Injectable solution	1,206,771 L.L
L01FG01	STIVANT	BioTech	Bevacizumab - 400mg/16ml	400mg/16ml	Injectable concentrate for solution	27,359,527 L.L
M03AX01	NEURONOX	BioTech	Clostridium botulinum type A neurotoxin complex - 50units	50units	Injectable lyophilised powder for solution	8,904,323 L.L
B01AB05	PARINOX 80	BioTech	Enoxaparin sodium - 8000IU (80mg)/0.8ml	8000IU (80mg)/0.8ml	Injectable solution	494,022 L.L
L01FG01	ZIRABEV	BioTech	Bevacizumab - 400mg/16ml	400mg/16ml	Injectable solution	49,965,229 L.L
M03AX01	XEOMIN	BioTech	Clostridium botulinum type A neurotoxin complex - 50 units LD50	50 units LD50	Injectable powder for solution	11,920,109 L.L
L04AC05	STELARA	BioTech	Ustekinumab - 130mg	130mg	Injectable concentrate for solution	L.L
B01AB05	ENOMEX	BioTech	Enoxaparin sodium - 6000U Anti-Xa/0.6ml	6000U Anti-Xa/0.6ml	Injectable solution	922,772 L.L
L01FG01	AVASTIN	BioTech	Bevacizumab - 100mg/4ml	100mg/4ml	Injectable concentrated solution	24,533,456 L.L
L04AC16	TREMFYA	BioTech	Guselkumab - 100mg/ml	100mg/ml	Injectable solution	L.L
B01AB05	ENOXA MEDIS	BioTech	Enoxaparin sodium - 6,000U Anti-Xa/0.6ml	6,000U Anti-Xa/0.6ml	Injectable solution	765,990 L.L